Monte Rosa Therapeutics Appoints Dr. Jan Skvarka to Board of Directors
BOSTON, March 23, 2023 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a clinical…
BOSTON, March 23, 2023 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE), a clinical…
SAN DIEGO, March 23, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology…
SAN DIEGO, March 23, 2023 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology…
VANCOUVER, British Columbia, March 23, 2023 (GLOBE NEWSWIRE) — Psyence Group Inc (CSE:PSYG | OTCQB:…
VANCOUVER, British Columbia, March 23, 2023 (GLOBE NEWSWIRE) — Psyence Group Inc (CSE:PSYG | OTCQB:…
WESTLAKE VILLAGE, Calif., March 23, 2023 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX) (“Genelux” or…
WESTLAKE VILLAGE, Calif., March 23, 2023 (GLOBE NEWSWIRE) — Genelux Corporation (NASDAQ: GNLX) (“Genelux” or…
– Initial first-in-human clinical data for IL-2 INDUKINE WTX-124 monotherapy expected in 4Q 2023 from…
– Initial first-in-human clinical data for IL-2 INDUKINE WTX-124 monotherapy expected in 4Q 2023 from…
CHATHAM, N.J., March 23, 2023 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a…
CHATHAM, N.J., March 23, 2023 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a…
The biotechnology company will debut its first product at the in-cosmetics Global trade show from…
The biotechnology company will debut its first product at the in-cosmetics Global trade show from…
TORONTO, March 23, 2023 (GLOBE NEWSWIRE) — Today, Arch Biopartners Inc., (“Arch” or the “Company”)…
TORONTO, March 23, 2023 (GLOBE NEWSWIRE) — Today, Arch Biopartners Inc., (“Arch” or the “Company”)…
Company continues design advancements of biologic-based materials for soft tissue repair and reinforcement MALVERN, Pa.,…
Company continues design advancements of biologic-based materials for soft tissue repair and reinforcement MALVERN, Pa.,…
Validive® Phase 2b/3 VOICE Trial Anticipates Go/No-Go Interim Readout by End of Next WeekCamsirubicin Phase…
Validive® Phase 2b/3 VOICE Trial Anticipates Go/No-Go Interim Readout by End of Next WeekCamsirubicin Phase…
Collaboration will extend the applications of each company’s platform through discovery and development of novel…